Acelrx Pharmaceuticals Inc Revenue
What is the Revenue of Acelrx Pharmaceuticals Inc?
The Revenue of Acelrx Pharmaceuticals Inc is $622.000k
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Health Care sector on NASDAQ compared to Acelrx Pharmaceuticals Inc
What does Acelrx Pharmaceuticals Inc do?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Companies with revenue similar to Acelrx Pharmaceuticals Inc
- New World Resource has Revenue of $605.000k
- Natures Hemp has Revenue of CAD$606.363k
- IQ-AI has Revenue of £608.000k
- Imricor Medical Systems has Revenue of $616.000k
- Oxford BioDynamics Plc has Revenue of £618.000k
- Holy Crp Brands Inc has Revenue of CAD$621.908k
- Acelrx Pharmaceuticals Inc has Revenue of $622.000k
- Medigard has Revenue of AUD$623.740k
- Mondias Natural Products has Revenue of CAD$625.944k
- KWESST Micro Systems has Revenue of CAD$626.195k
- Eurocastle Investment has Revenue of €628.000k
- Spir Communication has Revenue of €633.000k
- ClearVue Technologies has Revenue of AUD$634.000k